Symptom Management Implementation of Patient Reported Outcomes in Oncology

NACompletedINTERVENTIONAL
Enrollment

42,808

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

March 31, 2023

Study Completion Date

June 9, 2025

Conditions
Other CancerGastrointestinal CancerThoracic CancerGynecologic Cancer
Interventions
OTHER

Stakeholder Survey (Control Period)

Before eSyM go-live, study team members from each site will solicit input via emailed survey, remote meetings and/or in-person meeting on the use of ePROs in oncology from stakeholders to obtain input regarding adaptation, anticipated challenges, and implementation.

OTHER

Stakeholder Survey (Intervention Period)

After eSyM go-live and on an ongoing basis, we will evaluate the implementation process at each of the sites with a focus on adoption, appropriateness, acceptability, sustainability, penetration, and scalability. We will do so through emailed surveys and/or discussions with health system leadership, clinicians, clinic support staff, and informatics/IT staff.

OTHER

Qualitative Interview

A small subset of patients and stakeholders were invited to take part in qualitative interviews after the eSyM trial rollout.

OTHER

SASS Questionnaire

"A subset of control and intervention patients will be asked to complete a research questionnaire called the SASS Questionnaire asking about their Self-efficacy, Attainment of information needs, Symptom burden, and Satisfaction with care."

OTHER

eSyM

The electronic symptom management (eSyM) program is the EHR-integrated ePRO program being evaluated through this trial.

Trial Locations (6)

26506

West Virginia University Medical Center, Morgantown

38120

Baptist Memoiral HealthCare, Memphis

04101

Maine Medical Center, Portland

02115

Dana Farber Cancer Institute, Boston

03756

Dartmouth-Hitchcock Medical Center, Lebanon

02905

Brown University Health (formerly Lifespan Cancer Institute), Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

RTI International

OTHER

collaborator

Baptist Memorial Health Care Corporation

OTHER

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

MaineHealth

OTHER

collaborator

West Virginia University

OTHER

collaborator

Lifespan

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT03850912 - Symptom Management Implementation of Patient Reported Outcomes in Oncology | Biotech Hunter | Biotech Hunter